Upload Avatar (500 x 500)
Xiangjun Zhou
Medical School
Wuhan University
Hubei
Language: English, Chinese
Kidney Stones
Prevention
Treatment
Urology
Renal Fibrosis
Acute Kidney Injury
Fibrosis
Pathophysiology
Clinical Research
Therapeutics
Areas of Focus
- Kidney stone disease prevention and treatment
- Acute kidney injury and fibrosis
Work Experience
- 2015.07-2020.12 Attending Physician, Urology Department, Renmin Hospital, Wuhan University
- 2015.09-2017.04 Visiting Scholar, Medical College of Georgia, USA
- 2020.12-present Associate Chief Physician, Urology Department, Renmin Hospital, Wuhan University
Academic Background & Achievements
- 2004.09-2009.06 Bachelor of Clinical Medicine, Hubei College of Medicine
- 2009.09-2012.06 Master of Surgery, Wuhan University
- 2012.09-2015.06 PhD in Surgery, Wuhan University
- Received two National Natural Science Foundation projects
Publications
- Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys, Zhao S, Cheng F, Zhou XJ, et al., 2021
- Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo, Zhou XJ, Zhao S, Li W, Cheng F, et al., 2021
- Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1, Zhou XJ, Li YW, Wu C, Cheng F, 2020
- Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI, Li BJ, Xia YQ, Mei SQ, Zhou XJ, Cheng F, 2023
- p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis, Ye ZH, Xia YQ, Li L, Zhou XJ, Fan Cheng F, 2023
Awards
- 2022 Hubei Province Science and Technology Progress First Prize: Key Techniques and Clinical Application of Minimally Invasive Treatment for Kidney Stones
